DGX
44
8
WMT
62
2
MLM
67
-5
CCI
33
3
AAP
38
3
ADT
22
2
GD
66
3
CB
60
16
MET
51
14
GILD
30
2
NTAP
55
-5
CNX
69
2
TGNA
48
8
PM
41
-9
SRCL
47
3
HST
54
2
CHRW
42
2
TROW
51
3
AIZ
69
3
NSC
48
-2
DGX
44
8
WMT
62
2
MLM
67
-5
CCI
33
3
AAP
38
3
ADT
22
2
GD
66
3
CB
60
16
MET
51
14
GILD
30
2
NTAP
55
-5
CNX
69
2
TGNA
48
8
PM
41
-9
SRCL
47
3
HST
54
2
CHRW
42
2
TROW
51
3
AIZ
69
3
NSC
48
-2
Financhill
Back

Exact Sciences 10K Form

Sell
33

EXAS
Exact Sciences

Last Price:
60.96
Seasonality Move:
21.59%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-01 10Q EXAS/Exact Sciences Quarterly
2023-08-01 10Q EXAS/Exact Sciences Quarterly
2023-05-09 10Q EXAS/Exact Sciences Quarterly
2022-11-03 10Q EXAS/Exact Sciences Quarterly
2022-08-02 10Q EXAS/Exact Sciences Quarterly
2022-04-26 10Q EXAS/Exact Sciences Quarterly

Receive EXAS News And Ratings

See the #1 stock for the next 7 days that we like better than EXAS

EXAS Financial Statistics

Sales & Book Value

Annual Sales: $2.5B
Cash Flow: $34.63M
Price / Cash Flow: 345.59
Annual Sales: $17.34
Price / Book: 3.52

Profitability

EPS (TTM): -1.13570
Net Income (TTM): $-204.15M
Gross Margin: $1.85B
Return on Equity: -6.62%
Return on Assets: -3.21%

Exact Sciences Earnings Forecast

Key Exact Sciences Financial Ratios

  • The Gross Profit Margin over the past 26 years for EXAS is 73.83%.
  • The Selling, General & Administrative Expenses for EXAS have been equal to 64.82% of Gross Profit Margin.
  • The Research & Development expenses have been 17.04% of Revenue.
  • The Interest Expense is -11.96% of Operating Income.
  • The Net Earning history of EXAS is -8.17% of Total Revenues.
  • Per Share Earnings over the last 26 years have been positive in 14 years.

Exact Sciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: EXAS
CUSIP: 30063P
Website: exactsciences.com

Debt

Debt-to-Equity Ratio: 0.75
Current Ratio: 2.32
Quick Ratio: 1.91

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 198.1

EXAS Technical Analysis vs Fundamental Analysis

Sell
33
Exact Sciences (EXAS) is a Sell

Is Exact Sciences a Buy or a Sell?

  • Exact Sciences stock is rated a Sell
    The current Exact Sciences [EXAS] share price is $60.97. The Score for EXAS is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.